Literature DB >> 32329847

MiR-214 promotes proliferation and inhibits apoptosis of oral cancer cells through MAPK/ERK signaling pathway.

H Zhang1, P Sun, Y-L Wang, X-F Yu, J-J Tong.   

Abstract

OBJECTIVE: To study the influences of micro ribonucleic acid (miR)-214 on the proliferation and apoptosis of oral cancer cells through the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) pathway.
MATERIALS AND METHODS: In this work, human oral cancer HB cell lines were cultured in vitro and then treated with phosphate-buffered saline (PBS) as Control group, with miR-214 mimics as miR-214 mimics group or with miR-214 mimics + ERK inhibitor U0126 as miR-214 mimics + U0126 group. The messenger RNA (mRNA) levels of miR-214 and ERK were determined using quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR), and the protein expression levels of phosphorylated ERK (p-ERK), ERK, proliferating cell nuclear antigen (PCNA), p21, and tubulin were measured via Western blotting (WB). Besides, the proliferation and apoptosis of cells in each group were evaluated via methyl thiazolyl tetrazolium (MTT) assay and Hoechst staining, respectively.
RESULTS: Compared with Control group, miR-214 mimics group exhibited increased expression of miR-214 in oral cancer cells (p<0.01), extremely raised expression levels of p-ERK and PCNA, but an extremely decreased protein expression level of p21 (p<0.01), whereas miR-214 mimics + U0126 group had remarkably lower levels of p-ERK and PCNA, and a considerably higher protein level of p21 than miR-214 mimics group (p<0.05). The qRT-PCR results showed no significant differences in the mRNA level of ERK among the three groups (p>0.05). In addition, the proliferation ability was enhanced successively in Control group, miR-214 mimics + U0126 group and miR-214 mimics group, and the increase was more notable in miR-214 mimics group, with statistically significant differences (p<0.05). Finally, it was found through the Hoechst apoptosis assay that compared with that in Control group, the cell apoptosis was notably inhibited in miR-214 mimics group, and it was greatly increased in miR-214 mimics + U0126 group.
CONCLUSIONS: MiR-214 increases p-ERK level and p-ERK/ERK to activate the MAPK/ERK signaling pathway, raise PCNA level, and decrease p21 level, thereby promoting cell proliferation and inhibiting cell apoptosis.

Entities:  

Year:  2020        PMID: 32329847     DOI: 10.26355/eurrev_202004_20834

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Research progress and clinical application prospects of miRNAs in oral cancer.

Authors:  Long Xing; Zhenghu Feng; Hongbing Nie; Meitian Liu; Yali Liu; Xiaohua Zhang; Haijing Zhou
Journal:  Mol Biol Rep       Date:  2022-06-20       Impact factor: 2.316

2.  Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.

Authors:  Patrice Cagle; Nikia Smith; Timothy O Adekoya; Yahui Li; Susy Kim; Leslimar Rios-Colon; Gagan Deep; Suryakant Niture; Christopher Albanese; Simeng Suy; Sean P Collins; Deepak Kumar
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

3.  To study the mechanism of Scutellariae Radix and Astragaloside in the treatment of lung cancer based on network pharmacology.

Authors:  Zijuan Wang; Lingpeng Meng; Jingyi Shan; Liangyu Pei; Leri Bao; Xi Li; Yudong Lin; Xian Gu; Zhenye Xu
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

Review 4.  The Functional Mechanism of MicroRNA in Oral Lichen Planus.

Authors:  Yunshan Li; Yaodong He; Junwei Xiang; Linfei Feng; Yuanyin Wang; Ran Chen
Journal:  J Inflamm Res       Date:  2022-07-26

5.  The miRNome of canine invasive urothelial carcinoma.

Authors:  Mara S Varvil; Taylor Bailey; Deepika Dhawan; Deborah W Knapp; José A Ramos-Vara; Andrea P Dos Santos
Journal:  Front Vet Sci       Date:  2022-08-22

Review 6.  Current Advances in the Management of Adult Craniopharyngiomas.

Authors:  Montserrat Lara-Velazquez; Yusuf Mehkri; Eric Panther; Jairo Hernandez; Dinesh Rao; Peter Fiester; Raafat Makary; Michael Rutenberg; Daryoush Tavanaiepour; Gazanfar Rahmathulla
Journal:  Curr Oncol       Date:  2022-03-04       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.